Recent Dealmaking (01/2004)
Executive Summary
Summarizing the month in European dealmaking.
You may also be interested in...
Bone Gets Lucky Break At Last With Medsenic Merger
Faced with a scarily short cash runway and an ongoing expensive mid-stage study of an allogeneic cell therapy for the treatment of delayed-union bone fractures, Bone Therapeutics has found a saviour in France's Medsenic.
Hikma Will Push Harder To Make M&A Happen
Following a challenging first half for Hikma, executive chairman and CEO Said Darwazah talks to Generics Bulletin about how the firm is planning to be more active in making deals happen, as well as how it plans to address pressures on its Generics division that led to two consecutive downgrades in guidance this year.
Amneal Expects Host Of New Launches To Drive Firm To Success
Despite a couple of setbacks during Q2, Amneal has sustained continual growth across its business, particularly in the injectables space.